{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T17:07:47Z","timestamp":1765040867731,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015124","name":"Abbott Molecular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.puhe.2018.09.024","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T08:10:45Z","timestamp":1545552645000},"page":"40-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Outcomes and costs of single-step hepatitis\u00a0C testing in primary care, Birmingham, United\u00a0Kingdom"],"prefix":"10.1016","volume":"166","author":[{"given":"M.","family":"Munang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Atherton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3079-8477","authenticated-orcid":false,"given":"S.F.","family":"Atabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"Combating hepatitis B and C to reach elimination by 2030","author":"World Health Organization","key":"10.1016\/j.puhe.2018.09.024_bib1"},{"year":"2014","series-title":"Guidelines for the screening, care, and treatment of persons with hepatitis C infection","author":"World Health Organization","key":"10.1016\/j.puhe.2018.09.024_bib2"},{"key":"10.1016\/j.puhe.2018.09.024_bib3","unstructured":"American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV guidance: recommendations for testing, managing and treating hepatitis C. Available from: http:\/\/www.hcvguidelines.org\/[Accessed 27th April 2017]."},{"issue":"1","key":"10.1016\/j.puhe.2018.09.024_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations for the treatment of hepatitis C 2015","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"year":"2017","series-title":"Hepatitis C in England: 2017 report","author":"Public Health England","key":"10.1016\/j.puhe.2018.09.024_bib5"},{"issue":"4","key":"10.1016\/j.puhe.2018.09.024_bib6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2893.2005.00698.x","article-title":"Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens","volume":"13","author":"Irving","year":"2006","journal-title":"J Viral Hepat"},{"issue":"18","key":"10.1016\/j.puhe.2018.09.024_bib7","first-page":"357","article-title":"Vital signs: evaluation of hepatitis C virus infection testing and reporting \u2014 eight U.S. Sites, 2005\u20132011","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR"},{"issue":"18","key":"10.1016\/j.puhe.2018.09.024_bib8","first-page":"362","article-title":"Testing for HCV infection: an update of guidance for clinicians and laboratorians","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR"},{"year":"2012","series-title":"Hepatitis B and C testing: people at risk of infection. NICE guideline (PH43)","author":"National Institute for Health and Clinical Excellence","key":"10.1016\/j.puhe.2018.09.024_bib9"},{"year":"2014","series-title":"Investigation of hepatitis C infection by antibody testing or combined antigen\/antibody assay. UK Standards for Microbiology Investigations (SMI) V5 issue 7","author":"Public Health England","key":"10.1016\/j.puhe.2018.09.024_bib10"},{"issue":"8","key":"10.1016\/j.puhe.2018.09.024_bib11","first-page":"351","article-title":"Implementation and evaluation of a multicomponent quality improvement intervention to improve efficiency of hepatitis C screening and diagnosis","volume":"40","author":"Hirsch","year":"2014","journal-title":"Joint Comm J Qual Patient Saf"},{"issue":"1","key":"10.1016\/j.puhe.2018.09.024_bib12","doi-asserted-by":"crossref","first-page":"ofv218","DOI":"10.1093\/ofid\/ofv218","article-title":"Clinical care pathways for patients with hepatitis C: reducing critical barriers to effective treatment","volume":"3","author":"Howes","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.puhe.2018.09.024_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2014.05.014","article-title":"Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C","volume":"61","author":"Chevaliez","year":"2014","journal-title":"J Clin Virol"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350618303135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350618303135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:30:30Z","timestamp":1758501030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350618303135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":13,"alternative-id":["S0033350618303135"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2018.09.024","relation":{},"ISSN":["0033-3506"],"issn-type":[{"type":"print","value":"0033-3506"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and costs of single-step hepatitis\u00a0C testing in primary care, Birmingham, United\u00a0Kingdom","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2018.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}